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The linear nature of eukaryotic chromosomes leaves natural DNA ends susceptible to triggering DNA
damage responses. Telomeres are specialized nucleoprotein structures that comprise the ‘‘end zone”
of chromosomes. Besides having specialized sequences and structures, there are six resident pro-
teins at telomeres that play prominent roles in protecting chromosome ends. In this review, we dis-
cuss this team of proteins, termed shelterin, and how it is involved in regulating DNA damage
signaling, repair and replication at telomeres.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The main of goal cell division is the accurate transfer of genomic
information from a cell to its progeny. Breaks in chromosomal DNA
threaten the genomic integrity of future cells, so sensitive and
complex mechanisms have evolved for recognizing and dealing
with such insults. The DNA damage response (DDR) consists of sen-
sors of damage, which trigger a signaling cascade that activates po-
tent cell cycle checkpoints that lead to cell cycle arrest or DNA
repair to join broken DNA ends [1]. Rampant breaks and repairs
lead to massive genomic instability, a phenotype ﬁrst noticed by
Muller and McClintock in the genomes of irradiated fruit ﬂies
and maize, respectively [2]. The linear nature of eukaryotic chro-
mosomes presents a difﬁcult problem for cells: how could the
DDR machinery distinguish the normal ends of chromosomes from
sites of DNA breaks? Or alternatively, how could it mask normal
DNA ends from inappropriately activating this response so that
cells can propagate? This obstacle has been deemed the ‘‘end pro-
tection problem” [3]. The fact that recombination and genomic
instability, like that seen with induction of DNA breaks, did not oc-
cur with normal chromosome ends, led Muller and McClintock to
postulate that these ends possess special qualities.chemical Societies. Published by E
rsity School of Medicine, 333
).In addition to the end protection problem, linear chromosomes
are susceptible to a second end-related phenomenon called the
‘‘end replication problem”. Because the DNA polymerase machin-
ery is unable to completely replicate the lagging chromosome
strand, each cell division contributes to progressive erosion of
chromosomal ends. This shortening poses a potential problem,
since the continuous loss of chromosomal DNA in each daughter
cell results in the erosion of vital genetic information, eventually
adversely affecting cellular homeostasis. It is estimated that 50–
200 base pairs of genomic DNA is lost with each round of DNA rep-
lication, resulting in a total loss of 2–10 kb of DNA over the lifetime
of long-lived organisms. So how could cells protect important
genes from being lost through this process?
In work by Blackburn, Greider and Szostak, that was awarded
the 2009 Nobel Prize in Physiology and Medicine [2], the structure
of the chromosome ends was discovered to be specialized nucleo-
protein structures that comprise the ‘‘end zone” of chromosomes
called telomeres. Telomeres consist of long stretches of TTAGGG
repeats that solve this problem by ﬁrst acting as a buffer of non-
coding sequences that prevent important genes from being lost.
Second, the GT-rich telomeric sequence serves as a substrate for
the telomerase enzyme complex, which is required to maintain
the size of the end zones by adding more TTAGGG repeats de novo
to chromosomal ends.
Telomeres also solve the end protection problem. The DNA
tracts of the end zone are not blunt ended. Instead, they terminate
in a long single-stranded (ss) run of the G-rich sequence on the 30lsevier B.V. All rights reserved.
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of DNA is postulated to fold back onto itself to invade the duplex
portion of telomeres, forming what is called the t-loop [4]. The t-
loop effectively sequesters the free ends of chromosomes, protect-
ing them from being sensed as double strand breaks. The second
solution to the end protection problem comes in the form of a
six protein complex called shelterin [5], which appear to bind
exclusively to telomeres. An expanding body of research is eluci-
dating the complex roles of these proteins in the protection of
chromosomal ends and the maintenance of genomic stability. In
this review, we will brieﬂy discuss how these players team up to
defend the end zone, as well as the DNA damage sensing and repair
responses that are triggered when these molecules are removed.
We will focus on current knowledge about mammalian telomere
biology derived from experiments based primarily on human cell
lines or mouse genetic systems. Finally, we will discuss some of
the experimental systems used to study the different shelterin
components and the DNA damage response at telomeres.
2. Shelterin: meet the starting line-up
The team of proteins charged with protecting the end zone is
called the shelterin complex [5], and consists of six main players:
TRF1, TRF2, TIN2, RAP1, TPP1 and POT1 (Fig. 1). Most are essential
to survival of mammalian cells, as depletion of shelterin compo-
nents either drives cells into cellular senescence or results in early
embryonic lethality. Together, these six proteins form a complex
which is charged with protecting chromosome ends from activat-
ing a DDR, inhibiting inappropriate repair mechanisms and main-
tenance of telomeric length and structure. However, each protein
plays a unique role in telomere homeostasis.
The two main proteins that anchor the complex to the double
stranded telomeric DNA are telomeric repeat-binding factors 1
and 2 (TRF1 and TRF2), which recognize TTAGGG repeats and bind
directly through their SANT/Myb domain [6]. Although TRF1 and
TRF2 have similar structure and protein binding domains, they re-
cruit different proteins to telomeres [7] and play unique roles in
protection of the end zone.
TRF1 is a negative regulator of telomere length [8,9]. It is essen-
tial to cellular function as its depletion results in cellular senes-
cence [10–12], TRF1 may act as a docking protein to recruit other
factors to telomeres as it can interact with non-shelterin proteins
that can be found at telomeres, including PINX1, ATM, BLM,Fig. 1. Shelterin: defender of the end zone. Shelterin is composed of six players:
TRF1, TRF2, TIN2, RAP1, TPP1 and POT1. TRF1 is a negative regulator of telomere
length and is required to prevent replication fork stalling at telomeres. TRF2–RAP1
protects telomeres from engaging in an ATM-dependent DNA damage response
(DDR), while TPP1–POT1 binds to the single-stranded overhang to protect
telomeres from activating an ATR-dependent DDR. Inappropriate activation of
repair pathways at telomeres results in chromosome fusions and genome instabil-
ity. TPP1–POT1 also regulates telomerase access to telomeres to inﬂuence telomere
length.DNA-PKcs, Tankyrase 1 and Tankyrase 2 [13]. A recent conditional
knockout approach to delete Trf1 in mouse embryo ﬁbroblasts
(MEFs) revealed novel functions for Trf1: that it may be important
for preventing telomere replication mistakes and protects telo-
meres against a fragile-telomere phenotype [10,11]. Furthermore,
Trf1 deﬁciency leads a modest increase in sister telomere fusions,
suggesting that it may play a role in telomere end protection
[11]. However, the role for Trf1 in mediating telomere end protec-
tion requires further research, since in vitro experiments using
puriﬁed proteins showed that in contrast to TRF2, TRF1 is unable
to inhibit end-joining of telomeric substrates [14].
TRF2 plays a prominent role in end protection as its loss is very
toxic to cells, initiating a potent DDR to result in cellular senes-
cence and very dramatic end-to-end chromosome fusion pheno-
type indicative of improper repair [15,16]. TRF2 also may play a
role in stabilizing telomere secondary structure as it has been
shown to facilitate t-loop formation in vitro [17]. TRF2 recruits
and facilitates the interaction between the repressor/activator pro-
tein 1 (RAP1) and the end zone [18] and also interacts with a vari-
ety of non-shelterin proteins that play roles at telomeres, including
ATM, the MRN complex, WRN, BLM, Ku86, ERCC1/XPF, PARP1 and
PARP2 [13]. As with TRF1, the importance of these interactions has
not been fully elucidated.
TRF1 and TRF2 are linked together by the TRF1-interacting nu-
clear protein 2 (TIN2). TIN2 has also been called the linchpin of
shelterin, as it is able to bind TRF1, TRF2 and TPP1, acting as a
bridge between the double stranded and single-stranded telomere
binding proteins. Stability of the entire six protein complex ap-
pears to depend upon TIN2 [19]. While it can bind to both TRF1
and TRF2, TIN2 exists in stoichiometric quantities enough to bind
each molecule of TRF1 or TRF2, suggesting that it may not always
bind to both proteins concurrently and that the shelterin complex
may not always exist with six components [20]. It was recently dis-
covered that TIN2 exists in two isoforms in human cells. One of
these isoforms, TIN2L, was shown to bind tightly to nuclear matrix
proteins suggesting a role in anchoring telomeres to the nuclear
matrix [21].
TPP1 can interact with both TIN2 and POT1, providing the
essential link for the recruitment of POT1 to telomeres [22]. As
with other members of shelterin, homozygous loss of Tpp1 is
incompatible with survival [23] and the depletion of Tpp1 through
genetic ablation [23], RNA interference [24], or expression of a mu-
tant that cannot interact with POT1 [24] leads to cellular conse-
quences consistent with POT1 loss. TPP1 can also interact with
telomerase, suggesting that it may play role in telomere length
maintenance by modulating telomerase access to telomeres [25].
The single-stranded telomere binding protein, Protection of
Telomere 1(POT1), has two highly conserved oligonucleotide/oli-
gosaccharide binding folds (OB folds) that show speciﬁcity for sin-
gle-stranded telomeric sequences and are essential for binding the
30 overhang [26]. Its recruitment to telomeres mainly depends
upon TPP1 [22]. POT1 plays a role in regulating telomere length
as knockdown of POT1 or Tpp1 in cells leads to telomere elonga-
tion [24,27]. It is also a vital player in protecting the telomere
end zone, since knockdown of POT1 also triggers chromosomal fu-
sions and cell death [28]. Mice have two orthologs of the gene,
named Pot1a and Pot1b [29,30]. Pot1a is essential to cells as tar-
geted deletion of this gene in the mouse is embryonic lethal very
early on in development and leads to chromosomal fusions in cul-
tured cells [29,30]. On the other hand, Pot1b is not essential for
survival as Pot1b/ mice are viable, and its deﬁciency in cells does
not produce as severe a phenotype compared to loss of Pot1a alone
or deletion of both Pot1a and Pot1b [30,31]. Recent studies have
implicated Pot1b in telomeric length maintenance; in particular,
the regulation of C-strand resection for the formation of the 30
overhang, which is greatly elongated following Pot1b loss [30–32].
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tionarily conserved members of shelterin, RAP1. In Saccharomyces
cerevisiae, rap1 binds directly to telomeric sequences, where it is
involved in the negative regulation of telomere length, inhibition
of fusions, and recruiting Sir proteins for silencing of gene near
the telomeric region [33]. However, in human cells, RAP1 is re-
cruited to telomeres by TRF2, and its association with the end zone
is dependent on this interaction [18]. In vitro studies in human cell
lines suggest that RAP1 may play a role in telomere length regula-
tion independent of its ability to localize to telomeres [34]. Bio-
chemical assays suggest that TRF2/RAP1 work in conjunction to
inhibit end-to-end chromosome fusions [14]. Recent dissections
of the roles of TRF2 vs. RAP1 involved the generation of a fusion
protein that allowed RAP1 localization to telomeres without TRF2
[35]. Using this approach, localization of RAP1 to telomeres inde-
pendent of TRF2 did not interfere with DNA damage signaling,
but was sufﬁcient to inhibit end-to-end chromosome fusions [35]
suggesting that RAP1 plays a role in repression of DNA repair
rather that damage sensing.
3. DNA damage sensing and signaling at telomeres
The canonical response to DNA double strand breaks in cells is a
complex multi-step cascade similar to classical signal transduction
pathways. In this model, DNA damage acts as a stimulus that is de-
tected by DNA damage sensing factors. These factors further acti-
vate the signal transducing kinase factors which amplify the
response, resulting in the upregulation of downstream effector
proteins [36]. At double strand breaks, the initial sensing of dam-
age occurs through factors, such as the Mre11/Rad50/Nbs1
(MRN) complex, which recruits and activates the DDR signal trans-
duction protein from the phosphatidylinositide 3-kinase-like ki-
nases family: ataxia-telengectasia mutated (ATM). ATM is
considered a master controller for responses to DNA double strand
breaks and serves as a kinase to propagate the DNA damage signal
by recruitment factors like the phosphorylated histone variant
H2AX (c-H2AX), the mediator of DNA damage checkpoint1
(MDC1), and p53 binding protein 1 (53BP1) [37]. An alternative
signaling pathway is routed through the ATM- and Rad50-related
protein (ATR) [37]. While ATM responds mainly to IR damage
and DSB, ATR responds mainly to UV damage, single-stranded
breaks and replication fork stalls. These types of damage leave
DNA exposed as a single-stranded section of nucleotides. In this
pathway, replication protein A (RPA) recognizes and binds to the
ssDNA. It then recruits ATR/ATRIP, which transduces the DNA dam-
age signal to downstream factors. Both ATM and ATR propagate
damage signals through phosphorylation of downstream check-
point molecules, such as Chk1, Chk2 and the tumor suppressor
p53, which can lead to cell cycle arrest [38].
The theory that telomeres are involved in protection of chromo-
some ends from the DDR was ﬁrst demonstrated in cells and mice
with severe telomere shortening [39]. The role shelterin proteins
play in suppressing this response has been teased out through
the use of MEFs with genetic ablation of various combinations of
these factors. These studies take advantage of a technique that de-
tects the DDR proteins, including c-H2AX or 53BP1, at the sites of
DNA damage and along the surrounding chromatin as DNA damage
foci. Co-localization of these damage foci with telomere signals are
called telomere-induced damage foci (TIFs) [36,40]. These tech-
niques revealed that Trf2 and Pot1a play separate roles in telomere
end protection [41].
First, Trf2 knockdown experiments show that cells respond to
loss of Trf2 is a similar manner as IR-induced DSB, with the MRN
complex required for the initial sensing of damage at dysfunctional
telomeres [42,43] and ATM necessary for propagation of the signal[24,41]. Cells deﬁcient in either ATM or components of the MRN
complex (Mre11 or Nbs1) were unable to form TIFs in response
to Trf2 loss. However, ATR deﬁciency had no effect [24,41–43].
On the other hand, Tpp1 or Pot1a/b disruption leads to a DNA dam-
age signaling response that is dependent upon the ATR pathway.
MEFs that have been depleted of Pot1a/b either through genetic
ablation or through Tpp1 disruption readily formed TIFs in the ab-
sence of ATM, but failed to do so in the absence of ATR [24,41].
These results suggest that Trf2 acts mainly to repress ATM-medi-
ated DDR at dysfunctional telomeres, while Pot1a/b proteins are
involved in repression of the ATR pathway.
How TRF2 and POT1 act to inhibit these pathways is still un-
clear. Paradoxically, many components of DNA repair pathways
are can be found normally in the end zone without activating an
apparent DNA damage response [44]. Given that TRF2 can interact
with these non-shelterin telomeric factors, perhaps it directly sup-
presses their activation. In fact, there is some evidence that the
TRF2 interaction with ATM directly inhibit its activity [45]. How-
ever, POT1 has not been shown to interact with non-shelterin com-
ponents. Instead, it is postulated that the binding of the POT1 to
the 30 overhang provides protection through competitive blockade
of RPA binding to the single-stranded protrusion, preventing the
activation of the ATR pathway [46].
4. Mechanisms of repairing dysfunctional telomeres
To protect the integrity of the genome, the DDR machinery is
dispatched to ﬁx DNA breaks by recombining the broken ends, gen-
erating end-to-end fusions. However, this process may be detri-
mental in the context of large amounts of DNA breaks, since
these fusions form unstable dicentric chromosomes which break
as it pulled towards opposite ends of the dividing cell. The subse-
quent break must also be repaired and so a cycle of chromosome
breakage and fusions, also called the bridge-fusion-breakage
(BFB) cycle, begins [47]. With each round of improper fusions
and random breaks, gene losses and ampliﬁcations accumulate
and the resulting genomically unstable cells serve as a perfect ni-
dus for cancer formation [47]. Because each chromosome end rep-
resents a potential target for this repair process, repression of
repair processes at normal telomere ends is essential for genomic
stability.
Mammalian cells have developed two primary pathways for
repairing DSB: classical non-homologous end-joining (C-NHEJ)
and homologous recombination (HR) [1]. C-NHEJ is an error-prone
repair mechanism that joins two blunt ends of a break [48]. Brieﬂy,
the free ends are recognized and bound by the Ku70/86 protein
complex, which aligns the DNA breaks. DNA-PKcs, another kinase
of the PIKK family, is recruited to the damage sites by Ku70/80
and facilitates the activation of further downstream effectors to
initiate DNA end processing through nucleases such as Artemis.
DNA ligase IV (Lig4), in complex with XRCC4, performs the ﬁnal
act of ligating the two ends together [48]. The effects of dysfunc-
tional telomeres that are repaired by the C-NHEJ pathway can be
visualized on a chromosome metaphase spread as end-to-end fu-
sions. C-NHEJ appears to be the primary method of repair of telo-
meres that have lost Trf2, as depletion of Trf2 from MEFs results
in rampant chromosome end-joining processes that lead to dra-
matic fusion of chromosome ends [49]. This repair phenotype is
dependent on the canonical C-NHEJ pathway because it requires
Ku70 [50] and Lig4 [49] proteins. It also requires upstream signal-
ing from ATM [41,49] and 53BP1, which is involved in chromatin
mobility to position ends to facilitate end-joining [51].
The MRN complex, which is important for the initial detection
of telomere damage, is also involved in the telomere repair process,
as cells with Mre11 or Nbs1 deﬁciency cannot form end-to-end fu-
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has given insight into how Mre11 speciﬁcally plays a role in end
processing for DNA repair. Mre11 has been shown to have both
endonuclease and exonuclease activities in vitro [52]. Using an
Mre11 nuclease dead mutant [53], recent data suggest that
Mre11 nuclease activity is important for creating the proper sub-
strate for C-NHEJ when Trf2 is lost [42]. The ERCC1/XPF nuclease
complex has also been implicated in the processing of the G-over-
hang after Trf2 loss [54]. In both cases, the G-overhang is unable to
be removed after Trf2 loss, and the remaining single-stranded tail,
still bound by Tpp1/Pot1a/b, acts as a barrier to C-NHEJ [42,54]. Fu-
ture studies may help us to understand the interplay between
Mre11 and ERCC1/XPF in this resection process.
A more accurate method of DNA repair is HR, which uses the
homologous sequence from sister chromatids as templates to repli-
cate the damaged sequences [48]. The initial step of HR involves
resection of the DNA ends to form single-stranded overhangs. This
process also requires the MRN complex to secure the separate DNA
ends and the associated protein CTIP to help process the ends into
single strands that can then invade the sister chromatid [48]. Visu-
alization of this process at telomeres can also be seen onmetaphase
spreads through the use of a labeling technique called chromosome
orientation FISH (CO-FISH) [13]. This technique differentially labels
the G-rich and C-rich strands so that sister chromatids can be dis-
tinguished as individual green and red signals on normal telomeres.
Telomere recombination events through HR, called telomere sister
chromatid exchanges (T-SCEs), will co-label with both red and
green probes [55]. In contrast to TRF2, POT1 does not seem to play
a prominent role in repressing C-NHEJ as it loss leads to few end-to-
end fusions in both human cells [28] and mouse cells depleted of
Pot1a [29,30]. Instead, POT1 appears to repress HR-mediated repair
at telomeres, since Pot1a depletion in MEFs is accompanied by in-
creased T-SCEs [29], suggesting that the resulting unprotected sin-
gle-stranded G-overhang may serve as a substrate for HR.
C-NHEJ was once thought to play a prominent role in the inap-
propriate repair of critically shortened telomeres in the telomerase
knockout mice [56]. Because severe erosion of telomere tracts
leaves chromosome ends without the protective end zone, they
are thought to be ideal substrates for C-NHEJ. However, a recent
study demonstrated that chromosomal fusions in cells with se-
verely shortened telomeres does not require two major compo-
nents of the NHEJ pathway, DNA-PKcs and DNA ligase IV (Lig4)
[57]. This study suggests that inappropriate repair of critically
short telomeres may not be solely mediated by C-NHEJ. Alternative
NHEJ (A-NHEJ) pathways are currently being explored as possible
mechanisms for repair of dysfunctional telomeres [48]. Future
work may help to sort out the mechanism of A-NHEJ at telomeres
and the role shelterin plays in repressing this pathway.
5. Shelterin’s role in the generation and protection of the 30
overhang
The unique structure of telomeres is an important line of de-
fense against DDR activation. The t-loop was ﬁrst visualized via
electron microscopy of crosslinked human telomeric DNA [4] and
later conﬁrmed in telomeric chromatin [58]. While t-loop forma-
tion is not well understood, it is thought to be formed when the
single-stranded overhang loops back and invades the duplex telo-
meric sequences, forming the lariat shaped t-loop. However, there
is also a smaller D-loop of displaced telomeric DNA at the site of
invasion and this structure is reminiscent of the D-loop formed
during HR. Given that many HR factors are known to localize to
telomeres [44], it is postulated that both are formed through sim-
ilar processes. If this is the case, the process that prevents resolu-
tion of the Holliday junctions is not known. Perhaps the coatingof POT1 on the displaced strand inhibits this process. In vitro stud-
ies also suggest that TRF2 plays a role in facilitating the formation
of the t-loop [17].
Beyond the t-loop, evidence that shelterin plays an important
role in regulating the proper replication of telomeres and genera-
tion of the overhang is accumulating. The length of G-rich over-
hang is independent of telomerase activity and thought to be
produced through nuclease resection of the C-strand. In mouse
cells, Pot1b acts as a negative regulator of this nuclease process
since Pot1b deﬁciency leads to dramatic elongation of the G-rich
overhang [30,32,59]. However, the nuclease(s) that performs the
C-strand resection are yet unknown. Exo1 was ruled out when
MEFs that are genetically deﬁcient for both Pot1b and ExoI still
showed increased overhang production [32].
While the MRN complex is involved in the DNA damage sensing
and processing of dysfunctional telomere ends for NHEJ, increasing
evidence suggests that the MRN complex, especially Mre11, is also
involved in normal telomere end processing. First, the MRN com-
plex can be found at normal telomeres in a cell cycle dependent
manner, in the G2 phase [44]. Furthermore, Mrell has been impli-
cated to play a role in the generation of the 30 overhang in a telo-
merase-dependent manner in human cells as knockdown of
Mre11 leads to reduction of the overhang [60]. Recent data has
shown that depletion of Trf2 in the setting of MRN complex deﬁ-
ciency results in dramatic reduction of chromosome end-to-end
fusions due to failure to activate ATM signaling. Interestingly, this
situation results in an increase of leading-strand chromatid-type
fusions [42,43,61]. Chromatid-type fusions are generated during
G2, after DNA replication. Immediately following DNA replication,
telomeres created by leading-strand DNA synthesis are initially
blunt ended, and it is postulated that this blunt end could be rec-
ognized as a DSB during G2 [44]. In contrast, lagging-strand syn-
thesis results in telomeres possessing a 30 single-strand overhang
that is postulated to provide protection from C-NHEJ-mediated re-
pair. It is thought that TRF2 localization to newly replicated lead-
ing-strand telomeres would normally repress this DDR. In the
absence of TRF2, C-strand resection by the MRN complex is neces-
sary to generate the protective 30 overhang [42,43,61].
Recent data suggests that a 50–30 exonuclease called SMN1B/
Apollo may also play a role in the generation of the 30 overhang.
This protein was originally identiﬁed as a shelterin associated pro-
tein and localizes to telomeres via direct binding to TRF2 [62,63].
Initial experiments involving knockdown of SMN1B/Apollo by siR-
NA leads to cellular senescence and TIF formation in S-phase and
duplicated telomere ends, suggesting a role for SMN1B/Apollo in
telomere end processing during replication [62,63]. Recent work
using SMN1B/Apollo knockout MEFs reveal a 50% reduction in 30
single-strand overhang, a phenotype rescued by wild type
SMN1B/Apollo but not by mutants that do not possess nuclease
activity [64]. These results suggest that SMN1B/Apollo’s nuclease
activity plays an important role in end resection to generate 30
overhang at telomeres. Importantly, SNMIB/Apollo null MEFs exhi-
bit an increased incidence of chromatid-type fusions involving
leading-strand telomeres, consistent with its role in protecting
leading-strand telomeres after DNA replication. Mutations within
its conserved nuclease domain abolish this end-protective pheno-
type, suggesting that SNMIB/Apollo is a pivotal 50–30 exonuclease
required for generation of the protective 30 single-stranded over-
hangs at leading-strand telomeres after DNA replication to prevent
engagement of C-NHEJ [64].
6. In vivo consequences of shelterin disruption
Previous data on the in vivo consequences of telomere dysfunc-
tion has been largely obtained frommouse models based on genet-
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(mTR or mTERC) or the reverse transcriptase protein component
(mTERT) [39] and focused on telomere dysfunction induced by se-
vere telomere shortening. Because deﬁciency of most shelterin
components leads to early embryonic lethality, the bulk of our
knowledge about these defenders of the end zone has been eluci-
dated in cell culture experiments. However, studies focusing on
the in vivo consequences following shelterin disruption, using tis-
sue-speciﬁc conditional knockout or transgenic mouse models, are
beginning to emerge.
Pot1b is a rare exception in that it appears to be the only shel-
terin component that is not essential, since its knockout in mice
produce viable offsprings. However, Pot1b/ animals show abnor-
malities in highly proliferative organs, including increased apopto-
sis in intestines and testes [59], similar to the late generation
telomerase knockout mice [65]. Interestingly, combined Pot1b
deﬁciency with telomerase haploinsufﬁciency appear to induce
phenotypes similar to those seen in dyskeratosis congenita (DC)
[32,59]. DC is a human disease associated with mutations in the
telomerase complex that manifests characteristic phenotypes
including bone marrow failure, nail dystrophy and skin hyperpig-
mentation. All of these characteristics were observed in indepen-
dent Pot1b knockout, telomerase heterozygous mouse lines
[32,59]. These results suggest an essential role for Pot1b and other
shelterin components in maintaining highly proliferative tissue
compartments, a notion supported by the observation that some
cases of DC in humans is due to mutations in TIN2 [66].
Although homozygous deletion of Tpp1 is incompatible with
survival and leads to cellular consequences consistent with Pot1a
loss [23], there exists a mouse model of adrenocortical dysplasia
(acd) that was found to have a mutation in the Tpp1 gene [67].
The Tpp1/Acd mutation leads to splice variants of Tpp1 that de-
pletes the protein from telomeric ends and results in chromosomal
aberrations [68]. Acdacd/acd mice have skin abnormalities, poor
growth and survival, and defects in the development of organs de-
rived the urogenital ridge, manifesting in adrenal insufﬁciency,
hydronephrosis, and infertility due to gonadal defects [67]. These
traits can be reversed when p53 is deﬁcient, except for germ cell
atrophy [69]. The animals also show skeletal deformities resem-
bling caudal regression syndrome [67], a phenotype that is attrib-
uted to telomere dysfunction triggering p53-dependent apoptosis
[70]. Mice harboring the Tpp1/Acd mutation combined with deﬁ-
ciency of p53 also showed accelerated tumorigenesis, with a shift
in spectrum from lymphomas and sarcomas to carcinomas in a
p53+/ background [69], reminiscent of the cancer phenotypes ob-
served in the telomerase knockout mouse model [71].
One method of circumventing embryonic lethality is to condi-
tionally manipulate shelterin protein expression in a tissue speciﬁc
manner. Interestingly, while Trf2 loss is extremely toxic to MEFs in
culture, a model of hepatocyte-speciﬁc Trf2 deletion yielded mice
that showed no signs of liver dysfunction [72]. Despite evidence
of DDR activation, Trf2 depleted hepatocytes did not induce p53,
and cell death or senescence was not observed even after partial
hepatectomy. However, hepatocytes lacking Trf2 were unable to
undergo cell division, instead continuing to grow and replicating
the genome without dividing. These unusual results suggest a phe-
notype speciﬁc to liver tissue, in that liver regeneration can occur
by endoreduplication without cell division, thereby circumventing
problems due to chromosome fusions. Examination of a mouse
model in which Trf2 was conditionally overexpressed in the basal
cell and stem cells of the epidermis of mice resulted in signs of pre-
mature degeneration in the skin, including dryness, alopecia, and
hyperpigmentation, as well as development of spontaneous squa-
mous cell carcinomas in areas of skin exposed to light [73], pheno-
types that were accelerated when combined with telomerasedeﬁciency [74]. These results suggest that overexpression of Trf2
might promote cancer formation in highly proliferative tissues.
Trf1 loss has also been studied in the skin, as the Trf1 condi-
tional knockout mice was crossed with a K5-driven Cre transgene
[11]. The skin phenotype includes severe proliferative defects, po-
tent DDR activation in the targeted cells without changes in telo-
mere length, and a defect in the epidermal stem cell
compartment. The importance of the p53 tumor suppressor path-
way was highlighted once again when these animals were crossed
onto a p53 deﬁcient background – in addition to rescued mortality,
these animals with dual Trf1 and p53 deﬁciency spontaneously
developed invasive squamous cell carcinomas on the tail and ears.
These results suggest that Trf1 may play an unanticipated role in
maintaining telomere stability.
Taken together, these mouse models conﬁrm what has been
shown in cell culture experiments: disruption of the shelterin com-
plex leads to potent DDR activation in vivo. Furthermore, in the
setting of checkpoint deﬁciency, such as p53 loss, telomere dys-
function due to uncapping of shelterin proteins can generate geno-
mic instability and promote tumor formation, similar to mouse
models of severe telomere attrition [71]. However, these pheno-
types may be tissue speciﬁc, with the proliferative epithelial com-
partments, such as the skin, being more susceptible than other
organs, such as the liver. Future work may utilize these systems
to study telomere dysfunction in other epithelial organs systems,
such as the gastrointestinal tract or breast.
7. Conclusions
The 2009 Nobel Prize in Physiology and Medicine to Blackburn,
Greider and Szostak highlighted the important roles that telomere
and telomerase play to solve the end replication problem to main-
tain genome stability. Emerging evidence suggests that the core
telomere complex, shelterin, help solve the end protection problem
to defend the end zone. Shelterin components interact with mem-
bers of the DDR machinery to promote normal telomere metabo-
lism (for example, regulating telomere length and the generation
of the 30 overhang), but also must repress their deleterious effects
at telomeres (for example, inappropriate repair to produce end-to-
end chromosome fusions). Altering shelterin component levels in
both cells and mouse models result in genome instability, and in
the setting of p53 deﬁciency could promote neoplastic transforma-
tion in mouse models. The observation that TIN2 is mutated in hu-
man DC suggests that shelterin components may play important
roles in preventing the onset of proliferative disorders in stem cell
compartments, including cancer and aging. These phenotypes
should be further explored using conditional tissue speciﬁc ap-
proaches in mouse models of shelterin deﬁciency.
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